Entod Pharmaceuticals unveils cutting-edge R&D centre in Navi Mumbai biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Representative Image
MUMBAI: While treatment of mucormycosis the black fungus affecting a section of Covid-recovered patients has become synonymous with a 25-day course of an anti-fungal medication that costs more than Rs 30,000 daily, its shortage has forced city doctors to manage most with a medicine that costs Rs 350 or less a day.
“The drug, liposomal amphotericin B, has been in short supply for 9 days, prompting us to use the conventional amphotericin B that costs a fraction but gives equal results,” said ENT surgeon Dr Milind Navalakhe from Global Hospital, which has treated more than 35 patients in the past 60 days.
‘New amphotericin is Rolls Royce of mucor med but older one works too’
'Black fungus' operation: Maharashtra to train 100 ENT doctors | Mumbai News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
India is headed towards the fourth wave of the coronavirus, which could cause irreparable damage to its
population and economy. It can only be stopped by public awareness, sacrifice and cooperation.
Share Via Email
| A+A A-
India and the world are facing a vaccine crunch since the second and third waves are rising faster than the inoculation rate.
The frightening truth is that we do not know.
We do not know why after over 13 crore recorded Covid-19 infections, 30 lakh deaths, nearly 700 million vaccine doses given worldwide, including in India, the waves of death and destruction keep coming, crashing on the rocks of fear and speculation, threatening to drown humanity in its worst nightmare.